Drug Shortage Report for SODIUM ACETATE INJECTION, USP
| Report ID | 168505 |
| Drug Identification Number | 02139529 |
| Brand name | SODIUM ACETATE INJECTION, USP |
| Common or Proper name | SODIUM ACETATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM ACETATE |
| Strength(s) | 328MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-09-01 |
| Estimated end date | Unknown |
| Actual end date | 2025-04-21 |
| Shortage status | Resolved |
| Updated date | 2025-04-22 |
| Company comments | Long term supply status is currently unknown; however, we assure you we are working diligently with our plants on a resolution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-04-22 | English | Compare |
| v7 | 2025-04-21 | French | Compare |
| v6 | 2025-04-21 | English | Compare |
| v5 | 2024-09-24 | French | Compare |
| v4 | 2024-09-24 | English | Compare |
| v3 | 2022-09-02 | English | Compare |
| v2 | 2022-09-01 | French | Compare |
| v1 | 2022-09-01 | English | Compare |
Showing 1 to 8 of 8